Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Capital Expenditures (2020 - 2025)

Historic Capital Expenditures for GoHealth (GOCO) over the last 6 years, with Q3 2025 value amounting to $2.4 million.

  • GoHealth's Capital Expenditures fell 4425.11% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.5 million, marking a year-over-year decrease of 3899.51%. This contributed to the annual value of $13.7 million for FY2024, which is 2.18% down from last year.
  • As of Q3 2025, GoHealth's Capital Expenditures stood at $2.4 million, which was down 4425.11% from $2.8 million recorded in Q2 2025.
  • GoHealth's Capital Expenditures' 5-year high stood at $11.4 million during Q3 2021, with a 5-year trough of $532000.0 in Q4 2021.
  • Its 5-year average for Capital Expenditures is $3.6 million, with a median of $3.0 million in 2025.
  • As far as peak fluctuations go, GoHealth's Capital Expenditures plummeted by 9403.99% in 2021, and later surged by 29865.82% in 2023.
  • Quarter analysis of 5 years shows GoHealth's Capital Expenditures stood at $532000.0 in 2021, then surged by 166.17% to $1.4 million in 2022, then skyrocketed by 298.66% to $5.6 million in 2023, then crashed by 60.71% to $2.2 million in 2024, then rose by 6.9% to $2.4 million in 2025.
  • Its last three reported values are $2.4 million in Q3 2025, $2.8 million for Q2 2025, and $3.0 million during Q1 2025.